NCT04904744

Brief Summary

Our objective is to determine the effectiveness of varied outreach methods to children age 12-17 years old who are due for a well child check visit and don't have one scheduled in the next 45 days on the outcomes of appointment scheduling, appointment completion, and receipt of the COVID-19 vaccination.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,235

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 25, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 27, 2021

Completed
1 day until next milestone

Study Start

First participant enrolled

May 28, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2021

Completed
2.9 years until next milestone

Results Posted

Study results publicly available

October 28, 2024

Completed
Last Updated

October 28, 2024

Status Verified

August 1, 2024

Enrollment Period

5 months

First QC Date

May 25, 2021

Results QC Date

January 10, 2023

Last Update Submit

August 8, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Participants Who Completed an Adolescent Well-care Visit

    Participant completed adolescent well-care visit as determined by the presence of well-visit billing code documented in the electronic health record

    Within 8 weeks of the date of intervention or the date of randomization for the control group

Secondary Outcomes (3)

  • Number of Participants Who Scheduled an Adolescent Well-care Appointment

    Within 2 weeks of the date of intervention or the date of randomization for the control group

  • Participant Receipt of COVID-19 Vaccine

    Within 8 weeks of the date of intervention or the date of randomization for the control group

  • Family Member Receipt of COVID-19 Vaccine

    Within 8 weeks of the date of intervention or the date of randomization for the control group

Study Arms (3)

No message

PLACEBO COMPARATOR

No message sent

Other: No message

Low tailored message

ACTIVE COMPARATOR

2 text or phone reminders that child is overdue for well child check visit

Other: Low tailored message

Low tailored message plus COVID-19 vaccine message

ACTIVE COMPARATOR

2 text or phone reminders that child is overdue for well child check visit AND COVID-19 vaccine is available

Other: Low tailored message plus COVID-19 vaccine message

Interventions

2 low tailored text or phone message reminders that child is overdue for well child check visit

Low tailored message

No reminders are sent

No message

2 low tailored text or phone message reminders that child is overdue for well child check visit and that COVID-19 vaccine is available

Low tailored message plus COVID-19 vaccine message

Eligibility Criteria

Age12 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • age 12-17 years
  • has not had a well child check in past 365 days
  • no future well child check visit scheduled
  • parent preferred language = English or Spanish

You may not qualify if:

  • phone number not available in electronic health record

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, 45229-3039, United States

Location

Related Publications (1)

  • Burkhardt MC, Berset AE, Xu Y, Mescher A, Brinkman WB. Effect of Outreach Messages on Adolescent Well-Child Visits and Coronavirus Disease 2019 Vaccine Rates: A Randomized, Controlled Trial. J Pediatr. 2023 Feb;253:158-164.e1. doi: 10.1016/j.jpeds.2022.09.035. Epub 2022 Oct 4.

MeSH Terms

Conditions

Patient Acceptance of Health CareVaccine-Preventable Diseases

Interventions

NMT1 protein, S pombe

Condition Hierarchy (Ancestors)

Treatment Adherence and ComplianceHealth BehaviorBehaviorInfections

Results Point of Contact

Title
Dr. William B. Brinkman
Organization
Cincinnati Children's

Study Officials

  • William Brinkman, MD

    Cincinnati Children's

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 25, 2021

First Posted

May 27, 2021

Study Start

May 28, 2021

Primary Completion

October 31, 2021

Study Completion

December 10, 2021

Last Updated

October 28, 2024

Results First Posted

October 28, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations